Treatment uses radioisotopes produced in the University of Missouri Research Reactor.
![](https://nextgenmurr.missouri.edu/wp-content/uploads/2023/12/121323Pluvicto-1024x576.jpg)
Dec. 13, 2023
University of Missouri Health Care has initiated its first treatment using an FDA-approved targeted radioactive medicine for advanced metastatic prostate cancer.